Abstract #2950

GSH and GABA decreases in IDH1 mutated low-grade gliomas detected by HERMES spectral editing at 3 T in vivo

Tao Gong¹, Richard Edden^2,3, and Guangbin Wang¹

¹Shandong Medical Imaging Research Institute, Jinan, China, ²Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, United States, ³F. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, United States

IDH1 mutation could result in better prognosis compared with wild-type, but the mechanisms remain largely unknown. GABA and GSH are low-concentration metabolites, could not be detected using conventional MRS, but playing an important role in energy production of glioma. HERMES can be thought of as two MEGA-PRESS experiments with the benefit of saving half the acquisition time to simultaneously detect GABA and GSH. The results demonstrated that HERMES is a reliable tool for the simultaneous detection of GABA and GSH signals, and both of them decreased significantly in IDH1 mutated low-grade gliomas.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.